PubMed

Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study.

Custer B, Longstreth WT Jr, Phillips LE, Koepsell TD, Van Belle G.

BMC Cancer. 2006 Jun 7;6:152.PMID: 16759391 [PubMed - indexed for MEDLINE]Related articlesFree article

Exogenous hormone use and meningioma risk: what do we tell our patients?

Claus EB, Black PM, Bondy ML, Calvocoressi L, Schildkraut JM, Wiemels JL, Wrensch M.

Cancer. 2007 Aug 1;110(3):471-6. Review.PMID: 17580362 [PubMed - indexed for MEDLINE]Related articlesFree article

Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer.

Slattery ML, Potter JD, Curtin K, Edwards S, Ma KN, Anderson K, Schaffer D, Samowitz WS.

Cancer Res. 2001 Jan 1;61(1):126-30.PMID: 11196149 [PubMed - indexed for MEDLINE]Related articlesFree article

Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.

Chen WY, Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD, Colditz GA.

Cancer. 2004 Oct 1;101(7):1490-500.PMID: 15378477 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of low-dose oral contraceptives and stroke in young women.

Schwartz SM, Siscovick DS, Longstreth WT Jr, Psaty BM, Beverly RK, Raghunathan TE, Lin D, Koepsell TD.

Ann Intern Med. 1997 Oct 15;127(8 Pt 1):596-603.PMID: 9341057 [PubMed - indexed for MEDLINE]Related articlesFree article

Association of meningioma with reproductive factors.

Lee E, Grutsch J, Persky V, Glick R, Mendes J, Davis F.

Int J Cancer. 2006 Sep 1;119(5):1152-7.PMID: 16570277 [PubMed - indexed for MEDLINE]Related articles

Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.

Shantakumar S, Terry MB, Paykin A, Teitelbaum SL, Britton JA, Moorman PG, Kritchevsky SB, Neugut AI, Gammon MD.

Am J Epidemiol. 2007 May 15;165(10):1187-98. Epub 2007 Mar 3.PMID: 17337757 [PubMed - indexed for MEDLINE]Related articlesFree article

Hormonal and reproductive influences and risk of melanoma in women.

Smith MA, Fine JA, Barnhill RL, Berwick M.

Int J Epidemiol. 1998 Oct;27(5):751-7.PMID: 9839729 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk factors for hormone receptor-defined breast cancer in postmenopausal women.

Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C.

Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2482-8.PMID: 17164374 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of exogenous hormones hormones and risk of papillary thyroid cancer (Washington, United States).

Rossing MA, Voigt LF, Wicklund KG, Williams M, Daling JR.

Cancer Causes Control. 1998 May;9(3):341-9.PMID: 9684714 [PubMed - indexed for MEDLINE]Related articles

Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.

Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Marchbanks PA, Coates RJ, Norman SA, Weiss LK, Ursin G, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Spirtas R.

Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1175-81.PMID: 14652277 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk of venous thromboembolism in users of hormone replacement therapy.

Daly E, Vessey MP, Hawkins MM, Carson JL, Gough P, Marsh S.

Lancet. 1996 Oct 12;348(9033):977-80.PMID: 8855852 [PubMed - indexed for MEDLINE]Related articles

A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy.

Douketis JD, Ginsberg JS, Holbrook A, Crowther M, Duku EK, Burrows RF.

Arch Intern Med. 1997 Jul 28;157(14):1522-30. Review.PMID: 9236553 [PubMed - indexed for MEDLINE]Related articles

Hormonal factors and pancreatic cancer in women.

Kreiger N, Lacroix J, Sloan M.

Ann Epidemiol. 2001 Nov;11(8):563-7.PMID: 11709276 [PubMed - indexed for MEDLINE]Related articles

Is there an association between meningioma and hormone replacement therapy?

Blitshteyn S, Crook JE, Jaeckle KA.

J Clin Oncol. 2008 Jan 10;26(2):279-82.PMID: 18182668 [PubMed - indexed for MEDLINE]Related articles

A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones.

La Vecchia C, Ron E, Franceschi S, Dal Maso L, Mark SD, Chatenoud L, Braga C, Preston-Martin S, McTiernan A, Kolonel L, Mabuchi K, Jin F, Wingren G, Galanti MR, Hallquist A, Lund E, Levi F, Linos D, Negri E.

Cancer Causes Control. 1999 Apr;10(2):157-66.PMID: 10231164 [PubMed - indexed for MEDLINE]Related articles

Hormone replacement therapy and lung cancer risk: a case-control analysis.

Schabath MB, Wu X, Vassilopoulou-Sellin R, Vaporciyan AA, Spitz MR.

Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):113-23.PMID: 14734459 [PubMed - indexed for MEDLINE]Related articlesFree article

Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus.

Bernatsky S, Clarke A, Ramsey-Goldman R, Joseph L, Boivin JF, Rajan R, Moore AD, Leung MH, Allen A, Gordon C.

Rheumatology (Oxford). 2004 Sep;43(9):1178-81. Epub 2004 Jun 29.PMID: 15226516 [PubMed - indexed for MEDLINE]Related articlesFree article

Progesterone and estrogen receptors in meningiomas: prognostic considerations.

Hsu DW, Efird JT, Hedley-Whyte ET.

J Neurosurg. 1997 Jan;86(1):113-20.PMID: 8988089 [PubMed - indexed for MEDLINE]Related articles

Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women.

Schwartz AG, Wenzlaff AS, Prysak GM, Murphy V, Cote ML, Brooks SC, Skafar DF, Lonardo F.

J Clin Oncol. 2007 Dec 20;25(36):5785-92.PMID: 18089876 [PubMed - indexed for MEDLINE]Related articles